EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types

Haruka Onodera iD, Yohei Sato iD, Yosuke Komatsu iD, Makoto Yamashita iD, Yuta Watanabe iD, Takeshi Kokubo iD

Microorganisms · 21.07.2025 · 13 (7) · 1705

DOI: 10.3390/microorganisms13071705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 21.07.2025. Verfasst von Haruka Onodera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human milk oligosaccharides (HMOs) have garnered significant attention as one of the bioactive components in human milk, with growing applications in infant formula and food products. HMOs enhance butyrate production, which is produced by butyrate-producing bacteria such as Faecalibacterium prausnitzii and contributes to gut health through its diverse biological functions. However, the specific mechanisms by which individual HMOs promote butyrate production remain unclear. In this study, we conducted in vitro co-culture experiments of F. prausnitzii and Bifidobacterium bifidum, examining their relative abundance, fatty acid production, residual sugar levels, and gene expression. Our results revealed that B. bifidum utilizes HMOs and provides the constituent sugars to F. prausnitzii, thereby promoting butyrate production by F. prausnitzii. Furthermore, we found that the underlying mechanisms vary depending on the structure of the HMOs. Specifically, 2′-fucosyllactose and 3′-sialyllactose enhance the butyrate production efficiency of F. prausnitzii, while 6′-sialyllactose primarily promotes the growth of F. prausnitzii. These findings not only deepen our understanding of how HMOs influence infant gut health but also suggest new directions for developing nutritional products that leverage the distinct functional properties of each HMO.

Schlagwörter

Stichwörter der Autor:innen

Bifidobacterium bifidumFaecalibacterium prasunitziibutyratecross-feedinghuman milk oligosaccharides

Autor:innen und Institutionen

  • Institute of Health Sciences, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan.
  • Kirin Central Research Institute, Kirin Holdings Co., Ltd., 2-26-1-12-12 Muraoka-Higashi, Fujisawa 251-8555, Japan.

ORCID-Profile: Haruka Onodera, Yohei Sato, Yosuke Komatsu, Makoto Yamashita, Yuta Watanabe, Takeshi Kokubo

Zitieren

APA

Onodera, H., Sato, Y., Komatsu, Y., Yamashita, M., Watanabe, Y., & Kokubo, T. (2025). HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types. Microorganisms, 13(7), 1705. https://doi.org/10.3390/microorganisms13071705

Vancouver

Onodera H, Sato Y, Komatsu Y, Yamashita M, Watanabe Y, Kokubo T. HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types. Microorganisms. 2025;13(7):1705. doi:10.3390/microorganisms13071705

BibTeX
@article{Onodera2025,
  author = {Onodera, Haruka and Sato, Yohei and Komatsu, Yosuke and Yamashita, Makoto and Watanabe, Yuta and Kokubo, Takeshi},
  title = {HMOs Induce Butyrate Production of Faecalibacterium prausnitzii via Cross-Feeding by Bifidobacterium bifidum with Different Mechanisms for HMO Types},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {7},
  pages = {1705},
  doi = {10.3390/microorganisms13071705}
}
Kostenlos starten →